RESPONSIBLE PROVIDER IN ACCORDANCE WITH § 5 OF THE GERMAN TELEMEDIA ACT (TMG)
MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany
Telephone: +49 89 899 27-0
Fax: +49 89 899 27-222
Email: info@morphosys.com
RESPONSIBLE IN ACCORDANCE WITH § 18 PARA 2 OF THE GERMAN INTERSTATE TREATY ON BROADCASTING [MEDIENSTAATSVERTRAG – MSTV]
Charlotte Lohmann (Chief Legal Officer)
MorphoSys AG
MANAGEMENT BOARD
Jean-Paul Kress, M.D. (Chairman, CEO) and Lucinda Crabtree, Ph.D. (CFO)
CHAIRMAN OF THE SUPERVISORY BOARD
Marc Cluzel, M.D., Ph.D.
COMMERCIAL REGISTER
District Court of Munich, HRB 121023
VAT ID NO.
DE 155069821
REGULATORY AUTHORITY
Government of Upper Bavaria
REGISTERED TRADEMARKS
HuCAL®, HuCAL GOLD®, HuCAL PLATINUM®, Ylanthia®, 100 billion high potentials®, Monjuvi® and Minjuvi® are trademarks of the MorphoSys Group. Tremfya® is a trademark of Janssen Biotech, Inc. XmAb® is a trademark of Xencor, Inc.
DESIGN & PROGRAMMING
Digitas Pixelpark
www.digitaspixelpark.com
For better understandability, the use of male and female language forms is avoided. All personal descriptions apply equally to all genders.